Trial Details
COMPLETEDBasic Information
| Clinical ID | c558 |
|---|---|
| Identifier | NCT03860896 |
| Trial Title | GB004 in Adult Subjects With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: GB004|DRUG: Placebo|DRUG: GB004 |
Participant Information
| Sponsor | GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. |
|---|---|
| City | Monroe |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2019-04-24 |
|---|---|
| Primary Completion Date | 2019-12-17 |
| Completion Date | 2019-12-17 |